PINEAPPLE EXPRESS CANNABIS Co (PNXP)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.00
- As of
Kresmion compiles this page from PNXP's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PINEAPPLE EXPRESS CANNABIS Co (PNXP): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-05-05.
See the full PNXP dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PNXP on one page. Preview it with sample data, then open it live with a free account.
Preview the PNXP dossierActive events for PNXP
No recent events on PNXP in the last 180 days.
FREE, NO ACCOUNT
Every event on PNXP, as it fires
New filings, 13F moves and cross asset events on PNXP land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, PNXP
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
PNXP's 10-Q filed Dec 19, 2025 states:
These factors raise substantial doubt about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on PNXP
PNXP against its peers
PNXP's operating margin of -104.3% ranks in the 58th percentile of 12 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2024-12-31 and 2025-12-31.
| Metric | PNXP | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 16168 USD | 1.1M USD | 18 | 13 |
| Revenue YoY | n/a | 0.6% | n/a | 8 |
| Gross margin | n/a | 35.1% | n/a | 14 |
| Operating margin | -104.3% | -153.4% | 58 | 12 |
| Net margin | -192.7% | -153.6% | 41 | 15 |
Peers (17): KOAN, PTPI, OWPC, GCAN, GRPS, STEK, BTAIQ, SXTC, AYRWF, CBDY, NPHC, SKYI, KAYS, BSPK, IMCC, LVRLF, CPMD. Left out: FITY (no annual filing), XTXXF (period gap), BNIGF (no annual filing), NTRR (period gap), GREH (no annual filing), SFWJ (no annual filing), NASC (period gap), CBDL (no annual filing). Fiscal periods ending between 2024-12-31 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (PNXP: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in PNXP on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PNXP in the last 180 days.
Upstream: SEC EDGAR filings for PNXP
Kresmion, "PINEAPPLE EXPRESS CANNABIS Co (PNXP) institutional holdings and SEC filings", data as of 2026-05-05, https://kresmion.com/research/PNXP. Upstream data: SEC EDGAR filings for PNXP.
Link to this data (HTML):
<a href="https://kresmion.com/research/PNXP">PINEAPPLE EXPRESS CANNABIS Co (PNXP) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow PNXP on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PNXP for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.